Ildong Holdings Co., Ltd. (KRX:000230)
South Korea
· Delayed Price · Currency is KRW 6,920.00
+60.00 (0.87%)
At close: Jun 5, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Medicine Manufacturing and Sales | 600.40B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medicine Manufacturing and Sales Growth | -5.72% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Health Function Food | 12.45B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Health Function Food Growth | 9.10% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cosmetic Medical Devices | 10.04B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cosmetic Medical Devices Growth | 332.21% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Advertising Agency | 6.54B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Advertising Agency Growth | -14.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Water Ionizer | 4.43B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Water Ionizer Growth | -4.61% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Pharmacology Consulting | 3.08B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Pharmacology Consulting Growth | 14.95% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Holding Company | 1.31B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Holding Company Growth | -11.07% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Platform Service Delivery | 196.56M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Platform Service Delivery Growth | 4.35% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Software Development | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Software Development Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Device | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Device Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hyaluronic Acid and Filler | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hyaluronic Acid and Filler Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| South Korea | 624.52B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | -4.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan | 3.77B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 9.38B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -48.72% |
Log In |
Log In |
Log In |
Log In | Upgrade
|